Online Guided Compliance Webinar on Design Controls
(PRWEB) May 08, 2017 -- Cognition Corporation (http://www.cognition.us), a software company specializing in medical device compliance and commercialization, has just announced two upcoming spring webinars.
The free half-hour webinars, led by Cognition’s CEO David Cronin, will center around the Cockpit™ Platform and its approach to compliance with its guided approach to design controls. They will be held May 23 & 24.
“These are the first two webinars of our spring and summer webinar series,” says Mr. Cronin. “We’re very excited to have the opportunity to speak to the public about design controls and online guided compliance.”
Cognition’s approach to regulatory compliance includes specialized template sets for regulatory standards, including design controls exercises as explained in 21 CFR 820.30. The public webinars will take an in-depth look at the design controls process required by FDA and at Cognition’s design controls templates.
“We readily encourage anyone who is interested to sign up,” says Mr. Cronin. “We’ll dive into design controls and discuss exactly what having an online platform for design controls exercises means. It’s sure to be an informative experience for everyone.”
Spots are limited, so Cognition encourages everyone who is interested in attending the webinar to sign up soon. Those interested in signing up for the May 23 session can click here to be directed to the registration site. For the May 24 session, click here.
Cognition Corporation, based in Lexington, Massachusetts, has offered solutions for product development compliance for more than fifteen years. Cognition offers two core products: Cognition Cockpit™ and Cognition Compass™. Thousands of users worldwide use Cognition solutions to manage their product development process and meet regulatory, performance, and-time to-market goals. For more information, visit http://www.cognition.us or call (781) 271-9300.
###
Alex Critch, Cognition Corporation, http://www.cognition.us, +1 781-253-3387 Ext: 250, [email protected]
Share this article